Loading clinical trials...
Loading clinical trials...
A Disease Registry Encompassing the Care of Patients With Multiple Myeloma on Panobinostat (RECOMM)
Conditions
Interventions
Farydak
Locations
7
United States
American Health Network Indiana
Indianapolis, Indiana, United States
Southern Nevada Cancer Research Foundation and Optum Cancer Care
Las Vegas, Nevada, United States
Oncology Specialists of Charlotte
Charlotte, North Carolina, United States
Southern Oncology Specialists
Huntersville, North Carolina, United States
Gettysburg Cancer Center
Gettysburg, Pennsylvania, United States
Coastal Cancer Center
Myrtle Beach, South Carolina, United States
Start Date
November 4, 2019
Primary Completion Date
March 30, 2022
Completion Date
March 30, 2022
Last Updated
June 15, 2023
NCT07249528
NCT06215118
NCT06679101
NCT05969860
NCT06057402
NCT06383143
Lead Sponsor
pharmaand GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions